Land: Írland
Tungumál: enska
Heimild: HPRA (Health Products Regulatory Authority)
Benzylpenicillin procaine
Univet Limited
QJ01CE09
Benzylpenicillin procaine
300 milligram(s)/millilitre
Suspension for injection
POM: Prescription Only Medicine as defined in relevant national legislation
Bovine, Ovine, Porcine
procaine benzylpenicillin
Antibacterial
Authorised
1987-10-01
1. NAME OF THE VETERINARY MEDICINAL PRODUCT Unicillin 300mg/ml Suspension for Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Benzylpenicillin Procaine 300 mg EXCIPIENTS (PRESERVATIVE): Methyl Parahydroxybenzoate (E218) 1 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Suspension for injection. A white to off-white suspension. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, sheep and pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of infections caused by bacteria sensitive to penicillins in cattle, sheep and pigs. 4.3 CONTRAINDICATIONS Do not administer to animals known to be sensitive to penicillin. Do not use when it is known that penicillinase-producing staphylococcus organisms are present. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Occasionally in sucking and fattening pigs administration of products containing procaine penicillin may cause a transient pyrexia, vomiting, shivering, listlessness and incordination. Procaine penicillin G can, under certain circumstances, be toxic and even lethal to pigs and this is thought to be due to a sudden release of toxic amounts of free procaine. The symptoms include shivering, lassitude, inappetence, vomiting, cyanosis of the extremities and pronounced pyrexia (40°C and over). A vulval discharge may appear and some animals may abort. Alarming side-effects are most likely to occur when pigs with erysipelas are injected with an older and, or, heat- affected procaine penicillin formulation. Treatment with 5 mg dexamethasone will result in rapid recovery. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Use of this product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target bacteria. Whenever possible the product should only be used on the basis of susceptibility testing. Spe Lestu allt skjalið